JPH0320398B2 - - Google Patents
Info
- Publication number
- JPH0320398B2 JPH0320398B2 JP55183659A JP18365980A JPH0320398B2 JP H0320398 B2 JPH0320398 B2 JP H0320398B2 JP 55183659 A JP55183659 A JP 55183659A JP 18365980 A JP18365980 A JP 18365980A JP H0320398 B2 JPH0320398 B2 JP H0320398B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- ylthiomethyl
- tetrazol
- formula
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Laminated Bodies (AREA)
- Table Devices Or Equipment (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7931616A FR2472574A1 (fr) | 1979-12-24 | 1979-12-24 | Derives de cephalosporine et composition pharmaceutique les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56158787A JPS56158787A (en) | 1981-12-07 |
| JPH0320398B2 true JPH0320398B2 (enExample) | 1991-03-19 |
Family
ID=9233132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18365980A Granted JPS56158787A (en) | 1979-12-24 | 1980-12-24 | Cephalosporin derivative, its manufacture and antibacterial containing it |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4463173A (enExample) |
| EP (1) | EP0031708B1 (enExample) |
| JP (1) | JPS56158787A (enExample) |
| AT (1) | ATE7918T1 (enExample) |
| AU (1) | AU544374B2 (enExample) |
| CA (1) | CA1175805A (enExample) |
| CS (1) | CS226025B2 (enExample) |
| DD (1) | DD155520A5 (enExample) |
| DE (1) | DE3068273D1 (enExample) |
| DK (1) | DK552480A (enExample) |
| ES (2) | ES8201167A1 (enExample) |
| FI (1) | FI803817L (enExample) |
| FR (1) | FR2472574A1 (enExample) |
| GR (1) | GR71920B (enExample) |
| HU (1) | HU186289B (enExample) |
| IL (1) | IL61775A (enExample) |
| MW (1) | MW5380A1 (enExample) |
| NO (1) | NO803903L (enExample) |
| NZ (1) | NZ195731A (enExample) |
| PH (1) | PH21662A (enExample) |
| PL (2) | PL133508B1 (enExample) |
| PT (1) | PT72265B (enExample) |
| SU (2) | SU1031408A3 (enExample) |
| YU (2) | YU324680A (enExample) |
| ZA (1) | ZA807710B (enExample) |
| ZM (1) | ZM11380A1 (enExample) |
| ZW (1) | ZW31280A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2496666A1 (fr) * | 1980-12-22 | 1982-06-25 | Ici Pharma | Nouveaux derives de cephalosporine et composition pharmaceutique les contenant |
| FR2496665A1 (fr) * | 1980-12-23 | 1982-06-25 | Ici Pharma | Nouveaux derives de penicilline et composition pharmaceutique les contenant |
| ZA824094B (en) * | 1981-06-19 | 1983-07-27 | Ici Plc | A process for the manufacture of cephalosporin derivative |
| EP0071370A3 (en) * | 1981-07-23 | 1984-05-16 | Ici Pharma | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them |
| US4504478A (en) * | 1981-09-18 | 1985-03-12 | Imperial Chemical Industries Plc | Cephalosporin-1-oxide derivatives |
| EP0082648A3 (en) * | 1981-12-21 | 1984-09-26 | Imperial Chemical Industries Plc | Cephalosporin derivatives |
| JPS59110695A (ja) * | 1982-12-16 | 1984-06-26 | Asahi Chem Ind Co Ltd | 経口用セフアロスポリン |
| GR78718B (enExample) * | 1983-01-31 | 1984-09-27 | Ici Pharma | |
| US4855420A (en) * | 1983-06-03 | 1989-08-08 | Ici Pharma | Cephalosporin derivatives |
| GB8316589D0 (en) * | 1983-06-17 | 1983-07-20 | Ici Plc | Crystalline salts |
| US4547573A (en) * | 1983-12-02 | 1985-10-15 | Ici Pharma | Process for preparing cephalosporin derivatives |
| DK429986A (da) * | 1985-09-09 | 1987-03-10 | Otsuka Pharma Co Ltd | 2-oxa-isocephemforbindelser |
| US4760140A (en) * | 1986-10-20 | 1988-07-26 | American Cyanamid Company | 3-substituted-7-[5-substituted-2-thiazolyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid, diphenylmethyl esters |
| US6476220B2 (en) * | 2000-11-27 | 2002-11-05 | Aurobindo Pharma Limited | Process for the preparation of furaca |
| US20030135041A1 (en) | 2002-01-04 | 2003-07-17 | Orchid Chemicals & Pharmaceuticals Limited, India | Synthesis of ceftiofur intermediate |
| CA2737694C (en) * | 2008-09-26 | 2013-07-02 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| US9920014B2 (en) * | 2013-09-19 | 2018-03-20 | The Florida International University Board Of Trustees | Selective inhibition of bacterial topoisomerase I |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2430375A1 (de) * | 1973-06-26 | 1975-03-20 | Leo Pharm Prod Ltd | 7-amino-delta hoch 3 -cephem-4-carbonsaeure-derivate |
| US4358447A (en) * | 1979-04-27 | 1982-11-09 | Merck & Co., Inc. | 7-N-Heterocyclyl cephalosporins |
| EP0018595B1 (en) * | 1979-04-27 | 1986-08-20 | Merck & Co. Inc. | 7-n-heterocyclyl cephalosporins, a process for preparing and a pharmaceutical composition comprising the same |
| US4255424A (en) * | 1979-04-27 | 1981-03-10 | Merck & Co., Inc. | 7-N-Heterocyclyl 1-oxa, 1-aza, and 1-carbadethiacephalosporins |
| US4282219A (en) * | 1979-08-01 | 1981-08-04 | Merck & Co., Inc. | 7-N-Heterocyclyl cephalosporins and antibiotic pharmaceutical compositions containing them |
-
1979
- 1979-12-24 FR FR7931616A patent/FR2472574A1/fr not_active Withdrawn
-
1980
- 1980-12-01 GR GR63516A patent/GR71920B/el unknown
- 1980-12-03 NZ NZ195731A patent/NZ195731A/en unknown
- 1980-12-05 AU AU65134/80A patent/AU544374B2/en not_active Ceased
- 1980-12-09 ZA ZA00807710A patent/ZA807710B/xx unknown
- 1980-12-09 FI FI803817A patent/FI803817L/fi not_active Application Discontinuation
- 1980-12-17 HU HU803021A patent/HU186289B/hu unknown
- 1980-12-18 ZW ZW312/80A patent/ZW31280A1/xx unknown
- 1980-12-19 MW MW53/80A patent/MW5380A1/xx unknown
- 1980-12-20 PH PH24974A patent/PH21662A/en unknown
- 1980-12-21 IL IL61775A patent/IL61775A/xx unknown
- 1980-12-22 AT AT80304674T patent/ATE7918T1/de not_active IP Right Cessation
- 1980-12-22 DE DE8080304674T patent/DE3068273D1/de not_active Expired
- 1980-12-22 EP EP80304674A patent/EP0031708B1/en not_active Expired
- 1980-12-22 YU YU03246/80A patent/YU324680A/xx unknown
- 1980-12-22 NO NO803903A patent/NO803903L/no unknown
- 1980-12-22 PT PT72265A patent/PT72265B/pt unknown
- 1980-12-23 PL PL1980232847A patent/PL133508B1/pl unknown
- 1980-12-23 CS CS809244A patent/CS226025B2/cs unknown
- 1980-12-23 CA CA000367478A patent/CA1175805A/en not_active Expired
- 1980-12-23 ZM ZM113/80A patent/ZM11380A1/xx unknown
- 1980-12-23 DD DD80226584A patent/DD155520A5/de unknown
- 1980-12-23 PL PL1980228757A patent/PL132587B1/pl unknown
- 1980-12-23 SU SU803219703A patent/SU1031408A3/ru active
- 1980-12-23 DK DK552480A patent/DK552480A/da not_active Application Discontinuation
- 1980-12-24 US US06/219,879 patent/US4463173A/en not_active Expired - Lifetime
- 1980-12-24 ES ES498157A patent/ES8201167A1/es not_active Expired
- 1980-12-24 JP JP18365980A patent/JPS56158787A/ja active Granted
-
1981
- 1981-04-24 SU SU813274748A patent/SU1077573A3/ru active
- 1981-05-20 ES ES502352A patent/ES8204438A1/es not_active Expired
-
1982
- 1982-12-31 YU YU02926/82A patent/YU292682A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0320398B2 (enExample) | ||
| SE461913B (sv) | Nya beta-laktamasinhibitor-foereningar vilka aer mellanprodukter vid frammstaellning av antibiotiskt verksamma beta-laktamasfoereningar | |
| JPS60100585A (ja) | 新規セフエム化合物およびその製造法 | |
| KR910000035B1 (ko) | 세팔로스포린 화합물, 이의 제법 및 이를 함유하는 약학적 조성물 | |
| SE450384B (sv) | Nya cefemforeningar och forfarande for deras framstellning | |
| IE850866L (en) | Cephalosporins | |
| DE3586547T2 (de) | Antibakterielle verbindungen. | |
| DE3688087T2 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| DE2217563A1 (de) | Verfahren zur Herstellung von Acylaminoverbindungen | |
| US4492692A (en) | Cephalosporin derivatives | |
| DE69507887T2 (de) | Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen | |
| DE2607064A1 (de) | Neue 3-acyloxymethyl-cephem-verbindungen und verfahren zu deren herstellung | |
| JP3238209B2 (ja) | チオメチルチオカルバセファロスポリン誘導体 | |
| DE69613385T2 (de) | Cephemverbindungen | |
| JPH02138283A (ja) | ７‐アミノチアゾリルアセトアミドセファロスポラン酸の新規な０‐置換オキシム誘導体 | |
| US4118490A (en) | 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins and pharmaceutical compositions containing them | |
| JPS6310792A (ja) | 新規セフエム化合物 | |
| DE69418656T2 (de) | 2-acyloxycephemderivate als elastaseinhibitoren | |
| US4088761A (en) | 3-[(1,3-Dithiin-5-yl)-acetamido]-cephalosporins and antibacterial compositions containing them | |
| KR830000375B1 (ko) | 7-(α, α-2치환-아세타미도)-3-치환-3-세펨-4-카르복실산의 제조방법 | |
| WO2022189459A2 (en) | Novel galactoside inhibitor of galectins | |
| LU85101A1 (fr) | Antibiotiques du genre des cephalosporines | |
| EP0075434A2 (en) | Cephalosporins, their preparation and their pharmaceutical compositions | |
| JPH04211081A (ja) | セファロスポリン系抗生物質 | |
| JP2024501296A (ja) | ガレクチンの新規ガラクトシド阻害剤 |